Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile

Saved in:
Bibliographic Details
Main Authors: Radujković, Aleksandar (Author) , Boch, Tobias (Author) , Nolte, Florian (Author) , Nowak, Daniel (Author) , Kunz, Claudia-Elisabeth (Author) , Gieffers, Alexandra (Author) , Müller-Tidow, Carsten (Author) , Dreger, Peter (Author) , Hofmann, Wolf-Karsten (Author) , Luft, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 8 December 2020
In: Cancers
Year: 2021, Volume: 13, Issue: 4, Pages: 1-23
ISSN:2072-6694
DOI:10.3390/cancers12123683
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers12123683
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/12/12/3683
Get full text
Author Notes:Aleksandar Radujkovic, Tobias Boch, Florian Nolte, Daniel Nowak, Claudia Kunz, Alexandra Gieffers, Carsten Müller-Tidow, Peter Dreger, Wolf-Karsten Hofmann and Thomas Luft
Description
Item Description:Gesehen am 10.02.2022
Physical Description:Online Resource
ISSN:2072-6694
DOI:10.3390/cancers12123683